TMFUltraLong

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the health care sector, but also has a penchant for mining, retail, and automotive stocks, as well as personal finance and macroeconomic topics of interest.

TMFUltraLong’s Activity

Yesterday

NL

Article

TMFUltraLong published an article 12:00 AM

Could Galena Biopharma, Inc. Be Running Out of Money?

Running out of money is a serious concern for clinical-stage and early commercial stage biotech stocks. Let's take a closer look at Galena Biopharma and discover if investors have any reasons to be concerned about its current cash balance.

Fri Oct 17

NL

Article

TMFUltraLong published an article 12:00 AM

Better Dividend Stock: Caterpillar Inc. or Deere & Company?

Which is the better dividend stock: Caterpillar or Deere? Let's dig beyond just their current yields and find out.

Thu Oct 16

NL

Article

TMFUltraLong published an article 12:00 AM

Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?

This recently approved drug has record-breaking potential and could top $10 billion in sales within its first year. Find out the name of this drug and the company behind it.

NL

Article

TMFUltraLong published an article 12:00 AM

The 5 States With the Highest Cell Phone Bills

Cell phone taxes now account for nearly 16% of the average user's bill. Find out which five states will have consumers paying the most for their wireless service.

NL

Article

TMFUltraLong published an article 12:00 AM

Why Chesapeake Energy Corporation Stock Blasted Higher

Chesapeake Energy stock is among today's top gainers after announcing a mammoth asset sale to a rival. Is this deal truly as lucrative as today's share price move would indicate?

NL

Article

TMFUltraLong published an article 12:00 AM

A Quick Look at Celgene Corporation's Drug Development Pipeline

Celgene's drug development pipeline is currently firing on all cylinders; but can it stay that way for long? Find out as we take a closer look at the experimental drugs which matter most to Celgene.

Wed Oct 15

NL

Article

TMFUltraLong published an article 12:00 AM

We're Already in a Bear Market; You Just Don't Realize It Yet

The Dow Jones, S&P 500, and Nasdaq may not be down 20%, but this indicator would suggest we've already entered bear market territory. Find out what you should consider doing with your investment portfolio right now.

NL

Article

TMFUltraLong published an article 12:00 AM

The Best Way to Invest When the Stock Market Is Plunging

The best way to invest money when the stock market is falling is no secret.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be hitting a new 52-week low, but they may not be there for long!

NL

Article

TMFUltraLong published an article 12:00 AM

A Quick Look at Amgen, Inc.'s Drug Development Pipeline

Amgen's drug development pipeline is expected to deliver data on 10 late-stage candidates between 2014 and 2016. Find out what three studies are Amgen's most critical, as well as whether or not Amgen stock has the potential to head higher.

Tue Oct 14

NL

Article

TMFUltraLong published an article 12:00 AM

180 Million People Have This Disease, Yet Few Are Aware of It

75% of people with this potentially deadly disease are clueless they have it. Yet the interesting thing is we have the tools needed to practically eradicate it.

NL

Article

TMFUltraLong published an article 12:00 AM

Johnson & Johnson Earnings: Pharmaceutical Sales Again Lead the Way

Johnson & Johnson earnings top Wall Street estimates once again as strong pharmaceutical sales growth, led primarily by new drugs, helped offset negative currency translation and the loss of revenue from divested operational segments.

NL

Article

TMFUltraLong published an article 12:00 AM

A Quick Look at Pfizer Inc.'s Drug Development Pipeline

The success of Pfizer's drug development pipeline is critical if it's to overcome a sizable patent cliff. Find out which two developing drugs investors would be smart to monitor.

Mon Oct 13

Rule Breakers article.

TMFUltraLong published an update. 1:46 PM

NL

Article

TMFUltraLong published an article 1:24 PM

Why Alnylam Pharmaceuticals Surged Higher

1:20 p.m. EDT: Alnylam surges higher after an open-label midstage study reveals encouraging early efficacy for patisiran in patients with familial amyloidotic polyneuropathy.

NL

Article

TMFUltraLong published an article 12:00 AM

Good Thing This Tech Company is The Most Trustworthy -- It Knows All Your Secrets

Trust is the foundation of which all businesses are built upon -- even tech companies. Find out which surprising company knocked Apple to No. 2 and topped the list.

NL

Article

TMFUltraLong published an article 12:00 AM

Say What? Marijuana Legalization Would Bring in How Much in Tax Revenue?

Legalizing marijuana would bring in a staggering amount of tax revenue for the states. Find out just how much.

NL

Article

TMFUltraLong published an article 12:00 AM

A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline

Merck's drug development pipeline is the cornerstone of its future. Find out what key developing drugs investors should be the most focused on.

Fri Oct 10

NL

Article

TMFUltraLong published an article 1:24 PM

Why EXACT Sciences Corporation Is Today's Best Healthcare Stock

EXACT Sciences stock is among today's top gainers after the company received positive news from the Centers for Medicare and Medicaid Services. Find out what this means for investors.

NL

Article

TMFUltraLong published an article 12:00 AM

Retirement Income: 4 Ways to Boost Yours

Many Americans lack sufficient retirement income, but following these five simple steps could put you on the path to a comfortable retirement.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.95
Player Rank 36 out of 75062
Score 13951.37
Score Change Today -83.62
Accuracy 87.73%
Active Picks 111
Total Picks 506
Best Pick FAZ (+290.48)
Worst Pick PCYC (-3871.91)
Average Score per Pick 27.79
Charms Earned 15
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts